Efficacy of Exenatide Administered Twice Daily in Body Mass Index Reduction in Patients with Type 2 Diabetes Mellitus

Efficacy of Exenatide Administered Twice Daily in Body Mass Index Reduction in Patients with Type 2 Diabetes Mellitus

Background. Exenatide is a glucagon-like peptide-1 receptor agonist that can reduce body weight. This study aimed to determine the efficacy of exenatide on body mass index (BMI) reduction in patients with type 2 diabetes mellitus (T2DM) with differing baseline body weight, blood glucose, and atheros...

Full description

Saved in:
Bibliographic Details
Main Authors: Jie Zhang, Tong-Zhang Xian, Yu Teng, Xiuzhi Wang, Ming-Xiao Wu, Chen Li, Weihao Wang, Fuli Man, Xianbo Zhang, Xiaoxia Wang, Li-Xin Guo
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:International Journal of Clinical Practice
Online Access:http://dx.doi.org/10.1155/2022/7128859
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items